Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8459304 | Radiotherapy and Oncology | 2018 | 7 Pages |
Abstract
PROMs do not underestimate late side-effects at a group level. In spite of the low concordance rate, PROMS can be used to identify patients who experience a heavy burden of side-effects, requiring specific attention. Therefore, patients can be spared a visit to the OCLO.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
P.J.A.M. Brouwers, J. van Loon, R.M.A. Houben, J. Paulissen, S.M.E. Engelen, M. Heuts, M. de Boer, K. Verhoeven, D. De Ruysscher, L.J. Boersma,